Parametric Release Regulatory Requirements. Terry E. Munson Technical Vice President PAREXEL International, LLC
|
|
- Damon Hoover
- 6 years ago
- Views:
Transcription
1 Parametric Release Regulatory Requirements Terry E. Munson Technical Vice President
2 History First application approved for parametric release in 1985 Formed the basis for the FDA Compliance Policy Guide 7132a.13 issued in 1987 No further requests for parametric release until mid 90s FDA Submission Guideline issued February, 2010 October 22,
3 CPG 7132a.13 Defined Parametric Release as a sterility release procedure based upon effective control, monitoring, and documentation of a validated sterilization process cycle in lieu of release based upon end-product sterility testing Only applies to terminal moist heat sterilization of drug products October 22,
4 CPG 7132a.13 - Requirements Cycle has been validated to achieve microbial bioburden reduction to 10 0 with a minimum safety factor of an additional 6 log reduction. Cycle Validation Chamber Heat Distribution Load Configuration Heat Distribution Heat Penetration of Product Bioburden Studies Lethality Study referencing a test organism of known resistance Identify cycle parameters as Critical or non-critical Critical Time, Pressure, Temperature Non-Critical Heat-up Time, Cooling Time, etc. October 22,
5 CPG 7132a.13 - Requirements Failure of more than one critical parameter must result in automatic rejection of the sterilizer load Integrity of the container closure system has been validated Bioburden Testing Total Aerobic Count Total Spore Count For each batch October 22,
6 CPG 7132a.13 - Requirements Chemical or biological Indicators are included in each truck, tray or pallet of each sterilizer load. Chemical Indicators Cannot be used to evaluate cycle lethality Should have a time/temperature response Should be stable For each cycle - minimum degradation values established Biological Indicators Document biological indicator characteristics Can be used to evaluate cycle lethality Can be used in place of one critical parameter October 22,
7 CPG 7132a.13 - Requirements Reason for having indicators in each load GMP regulation 21 CFR (a) requires that for each batch of drug product purporting to be sterile and/or pyrogen free, there shall be appropriate laboratory testing to determine conformance to such requirements. October 22,
8 Submission Guideline Submission of Documentation in Applications for Parametric Release of Human and veterinary Drug Products Terminally Sterilized by Moist Heat Processes, February 2010 Applicable to Human and Animal Drugs and Biological products. Parametric Release is defined as a sterility assurance release program where demonstrated control of the sterilization process enables a firm to use defined critical process controls, in lieu of the sterility test to fulfill the intent of 21 CFR (a) and (a). October 22,
9 Submission Guideline Validation of the Sterilization Cycle Should be conducted in accordance with Submission of Documentation for Sterilization Process Validation in Applications for Human and Veterinary Drug Products, November 1994 Defines the criteria to be submitted in the application October 22,
10 Submission Guideline A sterilization load monitor, either in the form of a physical chemical or biological indicator, is included with each load to satisfy the requirement for a laboratory test. Required by (a) Must be placed in appropriate positions to indicate that the load was exposed to the sterilization process October 22,
11 Submission Guideline Content of the Submission Control Strategy for Terminal Sterilization Program Rationale for method used to monitor and control terminal sterilization process Rationale for selection of critical parameters Description of the acceptance criteria for parametric release Description of the proposed production loading pattern Description of microbiological monitoring plan for product and components October 22,
12 Submission Guideline Content of the Submission (cont.) Risk Assessment, process Understanding and Prior Knowledge Consistency of performance of the terminal sterilization cycle within validated limits Risk to sterility of product The terminal sterilization cycle Production loading pattern Container closure system Potential contamination risks from the environment Experience with the proposed or similar product or similar sterilization cycle Discussion of your overall prior knowledge and production and testing experience October 22,
13 Submission Guideline Content of the Submission (cont.) Documentation for Parametric Release Process Detailed description of the current terminal sterilization cycle Identification of the critical parameters minimum and maximum limits for each Certify that meeting critical parameters will be used as the primary release criterion for product release. Sterility test cannot be used to overrule failed cycles. Acknowledgement that any sample tested by the reference test method for sterility will pass October 22,
14 Submission Guideline Content of the Submission (cont.) Documentation for Parametric Release Process (cont) Description of the sterilization load monitors Type of monitor that will be used How the load monitor will be used and analyzed What functions are being measured by the monitor Rationale for the location of the monitor Recommends that Class 5 indirect monitors (ISO 15882, 2008) be used. Justification for the classification of the indirect monitors used Documentation of the control system to verify exposure of the load to the sterilization process Show the link between batch release criteria and the commitments in the application October 22,
15 Filing Must submit an application for new drug products Must submit a prior approval supplement for already approve drug products October 22,
16 FDA Approval Process Starts when application or supplement is accepted Reviewers will start review of the submitted documents At the same time a GMP status request is sent to the Office of Compliance in the respective Centers. Center for Drug Evaluation and Research Center for Veterinary Medicine Center for Biologics Evaluation and Research October 22,
17 FDA Approval Process (cont) The Office of Compliance will query their database for the sites listed in the application/supplement. If last inspection over two year will send a request for inspection to the appropriate District Office. If GMP status questionable - will send a request for inspection to the appropriate District Office. If inspection and GMP status is acceptable will inform reviewers that GMP status is acceptable Application/Supplement will be approved if GMP status is acceptable and the documentation in the application/supplement meets October 22,
18 EU Requirments In addition to the basic validation data the EU also Requires: Need sterility test history for acceptance A qualified sterility assurance engineer should be on site Need two independent systems to check for compliance to specifications October 22,
19 Future Manufacturers are still going to be slow to implement parametric release because of the addition requirements put on the sterilization process. October 22,
20 Contact Information Terry E. Munson Technical Vice President PAREXEL Consulting Phone: October 22,
Sterility Assurance and Risk Management: A CDER Microbiologist s Perspective
Sterility Assurance and Risk Management: A CDER Microbiologist s Perspective John W. Metcalfe, Ph.D. Senior Review Microbiologist FDA/CDER/OPQ/OPF/Division of Microbiology Assessment Center for Drug Evaluation
More informationSingle market, regulatory environment, industries under vertical legislation Pharmaceuticals : regulatory framework and market authorisations
EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals : regulatory framework and market authorisations Brussels,
More informationStonegate Pharmacy LP 11/10/16
Stonegate Pharmacy LP 11/10/16 November 10, 2016 2017 DAL WL 03 WARNING LETTER UPS Overnight Rene F. Garza, Pharm.D., Chief Executive Officer Stonegate Pharmacy, LP 2501 W. William Cannon Drive, Suite
More informationProduct Sterility Testing... To Test or Not to Test? That Is the Question
Product Sterility Testing... To Test or Not to Test? That Is the Question Elaine Daniell, Trabue Bryans, Kimbrell Darnell, Joyce Hansen, Victoria M. Hitchins, and Manuel Saavedra Abstract The applications
More informationSTERILITY TESTING OF PHARMACEUTICAL PRODUCTS
STERILITY TESTING OF PHARMACEUTICAL PRODUCTS Tim Sandle CONTENTS Introduction xiii 1 STERILITY 1 Introduction 1 Sterility 3 Microorganisms and Microbial Growth 5 Types of microorganisms 7 Sterilization
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Page 1 of 6 Home Inspections, Compliance, Enforcement, and Criminal Investigations Enforcement Actions Warning Letters Inspections, Compliance, Enforcement, and Criminal Investigations P.A. Benjamin Manufacturing
More informationMisconceptions with Moist Heat Sterilization Roy McLean
Misconceptions with Moist Heat Sterilization Roy McLean Senior Manager, Operations Support, R&D Sterility Assurance Baxter Healthcare Corporation 11 October 2018 1 A Famous Quote from The Big Short It
More informationResidual Solvents: FDA/ Regulatory Perspective
Rosa Motta Compliance Officer Residual Solvents: FDA/ Regulatory Perspective PDA/USP Residual Solvents Conference January 18-19, 2007 1 Outline Laws and regulations governing the compliance requirements
More informationHieber's Pharmacy 12/5/17
Hieber's Pharmacy 12/5/17 Division of Pharmaceutical Quality Operations I 10 Waterview Blvd, 3rd FL Parsippany, NJ 07054 Telephone: (973) 331-4900 FAX: (973) 331-4969 CERTIFIED MAIL RETURN RECEIPT REQUESTED
More informationRaritan Pharmaceuticals, Inc. 6/20/17
Raritan Pharmaceuticals, Inc. 6/20/17 U.S. Food & Drug Administration Division of Pharmaceutical Quality Operations I New Jersey District 10 Waterview Boulevard, 3rd Floor Parsippany, NJ 07054 June 20,
More informationLarry! 28/06/2016. House Keeping. Welcome! From the GoToWebinar page:
A Review of Sterilization Methods and Recommended Practices for Healthcare Facilities PART I June 30, 2016 Larry Talapa Welcome! Topic: A Review of Sterilization Methods and Recommended Practices for Healthcare
More informationDraft Guidance for Industry and FDA Staff
Draft Guidance for Industry and FDA Staff Submission and Review of Sterility Information in Premarket Notification (510(k)) Submissions for Devices Labeled as Sterile DRAFT GUIDANCE This guidance document
More informationTSDR Pharmacy Inc. dba brandmd Skin Care 11/9/17
TSDR Pharmacy Inc. dba brandmd Skin Care 11/9/17 Division of Pharmaceutical Quality Operations IV 19701 Fairchild, Irvine, CA 92612-2506 Telephone: 949-608-2900 Fax: 949-608-4417 WARNING LETTER VIA SIGNATURE
More informationPublic Health Service Food and Drug Administration Dallas District 4040 North Central Expressway Dallas, Texas
Department of Health and Human Services Public Health Service Food and Drug Administration Dallas District 4040 North Central Expressway Dallas, Texas 75204-3128 March 30, 2010 2010-DAL-WL-08 CERTIFIED
More informationThe proposed rule is significant, and the requirements and exceptions are complex. Key provisions of the proposal are described below.
ADVISORY Food & Drug FDA ISSUES PROPOSED RULE TO ESTABLISH A UNIQUE DEVICE IDENTIFICATION SYSTEM FOR MEDICAL DEVICES July 16, 2012 On July 11, 2012, the Food and Drug Administration (FDA) published in
More informationAKA Good Manufacturing Practice (GMP) Certification Program
AKA Good Manufacturing Practice (GMP) Certification Program Preamble The American Kratom Association (AKA) is establishing this program to assure the safety and integrity of kratom dietary supplements
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Page 1 of 8 Home Inspections, Compliance, Enforcement, and Criminal Investigations Compliance Actions and Activities Warning Letters 2014 Inspections, Compliance, Enforcement, and Criminal Investigations
More informationFDA 510(k) 101 The Basics
FDA 510(k) 101 The Basics Floyd G. Larson President, PaxMed International San Diego, CA OMTEC June 17, 2010 Chicago Agenda History of 510(k) process FDA s risk based approach FDA guidance and standards
More informationAseptic Process Simulation (APS) Program Risk Assessment
Aseptic Process Simulation (APS) Program Risk Assessment Angie Bragdon and Patrick Henderson Eli Lilly & Company Indianapolis Parenteral Manufacturing Agenda Background Process Case Studies Q&A 2 Background
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Page 1 of 9 Inspections, Compliance, Enforcement, and Criminal Investigations Phoenix Medical Devices, LLC 9/29/2009 Department of Health and Human Services Public Health Service Food and Drug Administration
More informationUnidirectional Airflow Smoke Test Protocol
Unidirectional Airflow Smoke Test Protocol Persons signing as approvers shall have examined the Unidirectional Airflow Protocol. This approval shall signify that testing of operational parameters is adequate
More informationExcipient Risk Assessment
Excipient Risk Assessment Richard O Sullivan- GMP Inspector GMP Conference 7 February 2017 Dublin Content Background 1 Guidance 2 HPRA Expectations 3 07/02/2017 2 Excipient Risk Assessment-Why? 07/02/2017
More information4/26/2013. Libia Lugo Drug Specialist San Juan District Office Investigations Branch
Libia Lugo Drug Specialist San Juan District Office Investigations Branch The Food and Drug Administration (FDA) responsibilities extend to the 50 United States, the District of Columbia, Puerto Rico,
More informationMonitoring The Sterilization Process. Are We Over The Top?
Monitoring The Sterilization Process. Are We Over The Top? Dr Brian Kirk, Senior Technical Services Specialist, Sterilization 3M Health Care Are We Over The Top? NO! Get it wrong and you kill the patient!
More informationHealthcare Sterilisation: Introduction and Standard Practices, Volume 1
Contents 1. Overview of Sterilisation and Background... 1 1.1 Magic Wand... 1 1.1.1 Definition of Sterilisation... 2 1.1.2 Detectives or Forensic Scientists... 3 1.1.3 Idealised Process... 6 1.1.4 Lesser
More informationA WHITE PAPER STERILITY TESTING ESSENTIAL THINGS YOU MUST KNOW
A WHITE PAPER STERILITY TESTING ESSENTIAL THINGS YOU MUST KNOW By Steven G. Richter, Ph.D 1. A WHITE PAPER STERILITY TESTING ESSENTIAL THINGS YOU MUST KNOW (includes combination products) Steven G. Richter
More informationDEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Apini$r$iy -tq 5-f
DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Apini$r$iy -tq 5-f J Dallas District 4040 North Central Expressway Dallas, Texas 75204-3145 Ref: 2004-DAL-WL-03 WARNING LETTER CERTIFIED MAIL RETURN
More informationIntroduction. Current status of 510(k) clinical data requirements. 1 Current Status&Considerations:
510(k) Current Status&Considerations: Conducting a Well-Controlled Clinical Study When Clinical Data is Required Introduction In an effort to promote innovation while protecting the population at large,
More informationTown and Country Compounding and Consultation Services, LLC 10/17/17
Town and Country Compounding and Consultation Services, LLC 10/17/17 Division of Pharmaceutical Quality Operations I 10 Waterview Blvd, 3rd FL Parsippany, NJ 07054 Telephone: (973) 331-4900 FAX: (973)
More informationPDA Points to Consider relating to EU GMP Annex 1 changes. Presented by Ashley Isbel 30 November, 2016
PDA Points to Consider relating to EU GMP Annex 1 changes Presented by Ashley Isbel 30 November, 2016 Lets get interactive! On your smart device, open a browser app and go to the link provided Click on
More informationValidation Introduction. Presented by John Montalto 27 March, 2013
Validation Introduction Presented by John Montalto 27 March, 2013 John Montalto Bachelor of Science Management Diploma >15 years of Industry Experience Consultant to United Nations various Government Regulatory
More informationStatus Update on the Review of DMFs
Status Update on the Review of DMFs Presented by Dave Skanchy, Ph.D. Director DMF Review Staff GPhA/FDA CMC Workshop June 4, 2013 1 Outline Changes to the DMF Review Staff: Update on GDUFA hiring and the
More information510(k) submissions. Getting US FDA clearance for your device: Improving
Getting US FDA clearance for your device: Improving 510(k) submissions Audrey Swearingen, RAC Director, Regulatory Affairs Telephone: +1 512.222.0263 Email: aswearingen@emergogroup.com Download this white
More informationHow Do You Know If a Sterilized Package Remains Sterile?
How Do You Know If a Sterilized Package Remains Sterile? 1 Acknowledgments Bioaerosol and Applied Microbiology Team Brian Heimbuch, MS Group Lead Del Harnish, MS Lead Technical Mike McDonald, MS Lead Engineer
More informationOverview of Dietary Supplement GMP Inspection Trends Quality Session 6
Overview of Dietary Supplement GMP Inspection Trends Quality Session 6 Presented by: Dean R. Cirotta, MBA President & Chief Operating Officer EAS Consulting Group, LLC 1700 Diagonal Road, Suite 750 Alexandria,
More informationHow Do You Know If Your Sterilized Instruments Remain Sterile?
How Do You Know If Your Sterilized Instruments Remain Sterile? Disclosure Harry Shaffer is the first author of the sterility maintenance study covered in this presentation and has been compensated by Halyard
More informationSandoz Inc. 12-Aug-08
Sandoz Inc. 12-Aug-08 Department of Health and Human Services Public Health Service Food and Drug Administration Atlanta District Office 60 8th Street, N.E. Atlanta, Georgia 30309 August 12, 2008 VIA FEDERAL
More informationReishi D. International, Inc. 2/6/18
Reishi D. International, Inc. 2/6/18 San Francisco District Office 1431 Harbor Bay Parkway Alameda, CA 94502-7070 Via UPS Overnight February 7, 2018 Mr. Zheng Xiong Li, CEO Reishi D. International, Inc.
More informationHOGAN & IFbuxrso~ LLP.
HOGAN & IFbuxrso~ LLP. C. STEPHEN LAWRENCE PARTNER (948) 940-0400 CSLAWRENCEBHHLAW. COM April 30, 1999 4675 MA- cow S V m 670 NEWPORT B UM, CA 92660 TEL (949) 250450 FAX (949) 83f0976 Janice Rullo President
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Page 1 of 5 Home Inspections, Compliance, Enforcement, and Criminal Investigations Enforcement Actions Warning Letters Inspections, Compliance, Enforcement, and Criminal Investigations V-SAB Medical Labs,
More informationAgency Information Collection Activities; Submission for Office of Management and
This document is scheduled to be published in the Federal Register on 02/19/2019 and available online at https://federalregister.gov/d/2019-02596, and on govinfo.gov 4164-01-P DEPARTMENT OF HEALTH AND
More informationSterilization of health care products Radiation. Part 2: Establishing the sterilization dose
Provläsningsexemplar / Preview INTERNATIONAL STANDARD ISO 11137-2 Third edition 2013-06-01 Sterilization of health care products Radiation Part 2: Establishing the sterilization dose Stérilisation des
More informationCertifications & Approvals
Certifications & Approvals Summary Food contact approvals. RoHS and WEEE European directives. UL/CSA. Packaging regulations. Other regulations. Where to find the ARMOR certificates. Certifications & Approvals
More informationComplex Medical Devices and Steam Sterilization. By Andrew Gay Director - Sterilizer Validation Australia
Complex Medical Devices and Steam Sterilization By Andrew Gay Director - Sterilizer Validation Australia About 10 years ago, during a routine Performance Qualification test, an observation was made that
More informationProper CMC Submission -API. Ramnarayan Randad, Ph.D. DMF Review Staff/OGD June 4, 2014 GPhA/FDA Bethesda, MD
Proper CMC Submission -API Ramnarayan Randad, Ph.D. DMF Review Staff/OGD June 4, 2014 GPhA/FDA Bethesda, MD 1 Type II Drug Master Files (DMFs) and GDUFA Generic Drug User Fee Amendments (GDUFA) July 9,
More informationFOOD SCIENCE AND NUTRITION
Food Science and Nutrition 1 FOOD SCIENCE AND NUTRITION Institute for Food Safety and Health Moffett Campus 6502 S. Archer Road Bedford Park, IL 60501 708.563.8271 appliedtech.iit.edu/food-science-and-nutrition
More informationLEAF Marque Assurance Programme
Invisible ISEAL Code It is important that the integrity of the LEAF Marque Standard is upheld therefore the LEAF Marque Standards System has an Assurance Programme to ensure this. This document outlines
More informationCurriculum Vitae. Lone Cleveland Andersen. Courses
Courses and continuing education, listed by subjects. GMP courses API Curriculum Vitae Lone Cleveland Andersen Courses ICH Q7; Compliance for API s manufactured by cell culturing and fermentation, European
More informationPlease find enclosed Dosimetry Service Licence No which replaces Dosimetry Service Licence No
Directorate of Nuclear Substance Regulation Telephone: 1 (888) 229-2672 April 12, 2017 Licence Number Christopher Passmore Landauer Inc. 2 Science Road Glenwood, IL 60425-1586 Subject: Dosimetry Service
More informationEU Regulatory Update & GMP Deficiencies. Bryan J Wright July 2017
EU Regulatory Update & GMP Deficiencies Bryan J Wright July 2017 Slide 1 PharmOut 2017 Outline Update on changes in EU GMP Guide Summary of GMP changes to the Guide Important details of changes over the
More informationFOOD AND DRUGS AUTHORITY (FDA) GHANA
REGULATION OF HERBAL MEDICINE IN GHANA FOOD AND DRUGS AUTHORITY (FDA) GHANA 1 PRESENTATION OUTLINE Background Mandate Functions General overview Regulation of Herbal Medicine Cooperation in the ECOWAS
More informationMHRA Pharmacovigilance Inspections: Prepare and Manage for Success
MHRA Pharmacovigilance Inspections: Prepare and Manage for Success Created and Presented by Miranda Dollen Vice President, Pharmacovigilance & EEA QPPV Mapi 2016, All Rights Reserved 2 Prepare and Manage
More informationBEST PRACTICE CHANGE CONTROL : DECIDING WHEN TO SUBMIT A 510(K) FOR A DEVICE CHANGE. Yuan Xu 18- JAN- 2018
BEST PRACTICE CHANGE CONTROL : DECIDING WHEN TO SUBMIT A 510(K) FOR A DEVICE CHANGE Yuan Xu 18- JAN- 2018 Background AGENDA What is Medical Device? What is 510(k)? Principles of best practices of device
More informationFood Safety Modernization Act - Impacts on the Grain and Feed Industry
Food Safety Modernization Act - Impacts on the Grain and Feed Industry NGFA 117th Annual Meeting and Convention March 17, 2013 San Francisco, California David Fairfield, NGFA Vice President of Feed Services
More informationAlignment of FSMA with Existing Food Safety Programs International Citrus & Beverage Conference
Alignment of FSMA with Existing Food Safety Programs International Citrus & Beverage Conference Donald Kautter US Food and Drug Administration Center for Food Safety and Applied Nutrition Office of Food
More informationAer ODE B3-20. Database System for GEX B3 Dosimetry. Aérial. Optical Dosimetry Equipment. (gamma and/or electron beam versions)
B3-20 Database System for GEX B3 Dosimetry (gamma and/or electron beam versions) and GEX combine to provide a Genesys 20 version of the flexible 21 CFR Part 11 certified database dosimetry system for use
More informationRevised August 28, 2018
Florida State University Human Subjects Committee Standard Operational Procedure (SOP) 7-IRB-26 Title: Responsible Executive: Approving Official: Prisoners as Research Subjects Gary K. Ostrander Gary K.
More informationTechnical requirements Nutrition products
Technical requirements Nutrition products Anna Kistauri Medicines and Nutrition Centre UNICEF Supply Division Nutrition Supplier Meeting 11 September 2013 Copenhagen Nutrition Unit Anthropometrics Supplementary
More informationInspections, Compliance, Enforcement, and Criminal Investigations. Central Texas Regional Blood & Tissue Center 07-Nov-03
1 of 7 6/10/2009 2:20 PM Inspections, Compliance, Enforcement, and Criminal Investigations Department of Health and Human Services Public Health Service Food and Drug Administration Dallas District 4040
More informationQA Program Evaluation Research Tool CF-195, Effective
COMPARISON OF THE CHARACTERISTICS OF RESEARCH, QUALITY IMPROVEMENT, AND PROGRAM EVALUATION ACTIVITIES RESEARCH QUALITY IMPROVEMENT PROGRAM EVALUATION COMMENTS INTENT Intent of project is to develop or
More informationSTANDARD FOR PORCINE SEMEN QUALITY IN AI CENTRES
STANDARD FOR PORCINE SEMEN QUALITY IN AI CENTRES 1 st November 2011 Page 1 of 17 BPEX STANDARD FOR PORCINE SEMEN QUALITY IN AI CENTRES 1. Legal Requirements 1.1 The collection, processing and distribution
More informationDETERMINING WHETHER AN ACTIVITY IS HUMAN SUBJECTS RESEARCH AS DEFINED BY FEDERAL REGULATIONS
Page 1 of 6 Human Research Protection Page: 1 of 6 DETERMINING WHETHER AN ACTIVITY IS HUMAN SUBJECTS RESEARCH AS DEFINED BY FEDERAL REGULATIONS DESCRIPTION Any proposed activity involving contact with
More informationAgency Information Collection Activities; Submission for Office of Management and Budget
This document is scheduled to be published in the Federal Register on 01/28/2016 and available online at http://federalregister.gov/a/2016-01690, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN
More informationTAMPA ELECTRIC COMPANY ENERGY SUPPLY HEARING CONSERVATION PROGRAM
TABLE OF CONTENTS TITLE PAGE # PURPOSE / INTRODUCTION / SCOPE 1, 2 ROLES AND RESPONSIBILITIES 2 EMPLOYEE TRAINING 3 ENGINEERING CONTROLS 4 NOISE EXPOSURE EVALUATION 4 SIGNAGE / POSTING 4-5 AUDIOMETRIC
More informationPIC/S GUIDANCE ON CLASSIFICATION OF GMP DEFICIENCIES
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 040-1 3 Appendices 1 January 2019 PIC/S GUIDANCE ON CLASSIFICATION OF GMP DEFICIENCIES PIC/S January 2019 Reproduction
More informationRisk Based Environmental Monitoring
Risk Based Environmental Monitoring Presented by Tanja Varglien, August 2018 Slide 1 PharmOut 2018 Agenda Module 1 What is Environmental Monitoring Module 2 Regulatory requirements Module 3 Risk-based
More informationCommitted to Environment, Health, & Safety
Committed to Environment, Health, & Safety Environment, Health, and Safety Management System and Policy of W. R. Grace & Co. November 8, 2018 The Grace Environment, Health, and Safety Management System,
More informationNew TGA Requirements for Microbiology
New TGA Requirements for Microbiology Karen Longstaff Ag. Chief Microbiologist Office of Laboratories and Scientific Services September 7, 2009 ARCS: Topics to cover What s new in TGO 77 Sponsor obligations
More informationINTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL
More informationMedidée Services SA. Nano-Tera.ch. 05 February 2015 part 4. Intro ISO GMP - GLP Pierre-Alain Sommer
Nano-Tera.ch 05 February 2015 part 4 Intro ISO GMP - GLP Pierre-Alain Sommer Pierre-alain.sommer@medidee.com www.medidee.com Nano-Tera 2015 05.02.2015 Introduction to ISO 13485, cgmp s and GLP s Context
More informationProficiency Testing Policy
Page 1 of 7 Reviewed by: Getnet Tsigemelak Approved by: Araya Fesseha Position: Deputy Director General Position: Director General Signature: Signature: Contents Page 1 Purpose...2 2 scope...2 3 References...2
More informationHealthcare Sterilisation: Challenging Practices Volume 2
Contents 1 Traditional Chemical Sterilisation Methods... 1 1.1 Ethylene Oxide Sterilisation... 3 1.1.1 Green sterilisation (Benefits versus Risks)... 4 1.1.2 Ethylene Oxide Residuals... 8 1.1.3 Advantages
More informationGuide to Registration of Homeopathic Veterinary Medicinal Products
Guide to Registration of Homeopathic Veterinary Medicinal Products AUT-G0047-3 16 NOVEMBER 2012 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes
More information040716_ANDI_VENTIS WEBSITE(new) Printout 1. HOME PAGE. Welcome to our world of Dry Powder Inhalers!
1. HOME PAGE Welcome to our world of Dry Powder Inhalers! Andi-Ventis Ltd, established in 2001 is a joint venture between Medochemie Ltd, Cyprus and Miat SpA Italy, founded to carry out the pharmaceutical
More informationAMERICAN BOARD OF CRANIOFACIAL DENTAL SLEEP MEDICINE
AMERICAN BOARD OF CRANIOFACIAL DENTAL SLEEP MEDICINE Requirements for ABCDSM Craniofacial Dental Sleep Medicine Credentialing I. Background Craniofacial Dental Sleep Medicine is the area of dentistry that
More informationPage 1132
Page 1131 Page 1132 Page 1133 Page 1134 Page 1135 Huntingdon Life Sciences 03-6140 Page 6. Final Report TABLE OF CONTENTS Page 1136 COVER PAGE...1 GLP STATEMENT...2 SIGNATURE PAGE...3 QUALITY ASSURANCE
More informationAlcohol and Drug Testing for Employees with Commercial Drivers' License
Alcohol and Drug Testing for Employees with Commercial Drivers' License Revised: 02/12 FSS/PPS 04.05.04 Issue No. 5 Reviewer: Director, Facilities Management Effective Date: 01/01/96 (E4Y) Review Date:
More informationALCOHOL AND DRUG-TESTING OF BUS DRIVERS REGULATION
REGULATION It is the District s intention to comply fully with the Omnibus Transportation Employee Testing Act of 1991 (P.L. 102-143) (the Omnibus Act ) and U. S. Department of Transportation (the DOT)
More informationSterile U Network. Quality Control for Table-top Steam Sterilizers. Introduction: T U T O R I A L S
3M Attest Products TM TM Sterile U Network T U T O R I A L S Quality Control for Table-top Steam Sterilizers Introduction: Many health care professionals in office-based settings are not aware that they
More informationANDA Submissions Refuse to Receive for Lack of Proper Justification of Impurity Limits Guidance for Industry
ANDA Submissions Refuse to Receive for Lack of Proper Justification of Impurity Limits Guidance for Industry DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments
More informationCase 2:18-cv JTF-dkv Document 1 Filed 09/25/18 Page 1 of 17 PageID 1 IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF TENNESSEE
Case 2:18-cv-02656-JTF-dkv Document 1 Filed 09/25/18 Page 1 of 17 PageID 1 IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF TENNESSEE ) UNITED STATES OF AMERICA, ) ) Civil No: 18-2656 Plaintiff,
More informationSterilization of health care products - Radiation - Part 2: Establishing the sterilization dose
AAMI/FDS-1 11137-02 2006-01-12 (Revision of ANSI/AAMI/ISO 11137:1994; AAMI/ISO TIR13409:1996; AAMI/ISO TIR15844:1998) Final draft American National Standard AAMI/ American National Standard NOTE - This
More informationINTRODUCTION TO DRUG LAW AND REGULATION: REGULATION OF DRUG MANUFACTURING
Food and Drug Law Institute's Workshop on INTRODUCTION TO DRUG LAW AND REGULATION: REGULATION OF DRUG MANUFACTURING November 8-9, 2010 Park Hyatt Hotel Washington, D.C. 1 REGULATION OF DRUG MANUFACTURING
More informationEnvironmental Certification Services Indoor Air Quality Certification Manual
SCS IAQ Certification Manual 2009. Scientific Certification Systems Environmental Certification Services Indoor Air Quality Certification Manual 402_MAN_IAQ_CertificationManual_V1 0_100509 1 of 5 Thank
More informationcgmp (21 CFR 111) Regulation and Compliance Overview
cgmp (21 CFR 111) Regulation and Compliance Overview Neogen Effective Compliance Seminar September 23, 2014 Michael McGuffin President, American Herbal Products Association mmcguffin@ahpa.org Regulation
More informationFILL AMOUNT CONTROL FOR LIQUID AND SEMISOLID DOSAGE FORMS
How to Facilitate First Cycle Approvals Recommendations and Expectations FILL AMOUNT CONTROL FOR LIQUID AND SEMISOLID DOSAGE FORMS Yaodong (Tony) Huang, Ph.D. Quality Assessment Lead (Acting) Branch VIII/Division
More informationATTACHMENT A AdvaMed Comments Draft-Guidance for Industry and FDA Staff -510(k) Modifications: Deciding When to Submit a 510(k) for a Change to an Existing Device Line(s) No. Line or lines numbers of the
More informationCO SPONSORED BY. November 14, 2018 DoubleTree by Hilton Hotel Rochester Rochester, MN
CO SPONSORED BY November 14, 2018 DoubleTree by Hilton Hotel Rochester Rochester, MN Good Manufacturing Practices (GMP) A Regulatory Overview and The Role of EHS in Pharmaceutical Manufacturing Compliance
More informationBrazilian Official Gazette (Diário Oficial da União DOU) of 1 February 2010
Brazilian Health Surveillance Agency www.anvisa.gov.br Draft Resolution No 10 of 27 January 2010. Brazilian Official Gazette (Diário Oficial da União DOU) of 1 February 2010 The Collegiate Directorate
More informationISO INTERNATIONAL STANDARD. Sterilization of health care products Radiation Part 2: Establishing the sterilization dose
INTERNATIONAL STANDARD ISO 11137-2 First edition 2006-04-15 Sterilization of health care products Radiation Part 2: Establishing the sterilization dose Stérilisation des produits de santé Irradiation Partie
More informationFood Additives Program
U.S. FDA s Food Additive Program: An Update on Resources and Challenges 18 th Food Packaging Law Seminar October 11, 2017 Arlington, VA 1 Food Additives Program Dennis Keefe, PhD Director, Office of Food
More informationRock Solid Nutrition, LLC 12/22/16
Rock Solid Nutrition, LLC 12/22/16 December 22, 2016 WARNING LETTER Kansas City District Office 8050 Marshall Drive - Suite 205 Lenexa, Kansas 66214-1524 913-495-5100 VIA UNITED PARCEL SERVICE OVERNIGHT
More informationAutism Speaks Translational Postdoctoral Fellowship Program 2011 Request for Applications
Autism Speaks Translational Postdoctoral Fellowship Program 2011 Request for Applications Deadlines: Letter of Intent: March 31, 2011, 8:00 p.m. (U.S. Eastern Time) Letters of recommendation and Application:
More informationISO 13485:2016 MEDICAL DEVICES QMS TRANSITION GUIDE
ISO 13485:2016 MEDICAL DEVICES QMS TRANSITION GUIDE ISO 13485, OVERVIEW ISO 13485 sets regulatory requirements or, when specified, customer requirements for a management system for medical devices or services.
More informationINTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL
More informationIssue Date: 5/15/18 Supersedes Version Dated: 8/1/16 Page 1 of 5
Issue Date: 5/15/18 Supersedes Version Dated: 8/1/16 Page 1 of 5 Product Information Ingredients Organic Certification Country of Origin Gluten-Free Allergen-Free Production Organic raw Shine Skin pumpkin
More informationGood Laboratory Practice. EU-Serbia screening meeting Brussels, 19 June 2014
Good Laboratory Practice EU-Serbia screening meeting Brussels, 19 June 2014 Table of contents 1. Background information on the principles of GLP 2. EU legal basis for GLP 3. Role of Member States 4. Role
More informationEnvironmental Monitoring How to Satisfy the Regulator. Presented by Tanja Varglien, July 2017
Environmental Monitoring How to Satisfy the Regulator Presented by Tanja Varglien, July 2017 Slide 1 PharmOut 2017 Using Glisser You will be able to tap the download link at the end of each presentation.
More informationModule 34: Legal aspects, ADI and GRAS status of food additives
Paper No.: 13 Paper Title: FOOD ADDITIVES Module 34: Legal aspects, ADI and GRAS status of food additives 34.1 Legal Aspects of Food Additives The data provided by Joint Expert Committee on Food Additives
More information